Immunotherapy for metastatic colorectal cancer: Present status and new options

Eva Ellebaek, Mads Hald Andersen, Inge Marie Svane, Per Thor Straten

    20 Citations (Scopus)

    Abstract

    Although no immunotherapeutic treatment is approved for colorectal cancer (CRC) patients, promising results from clinical trials suggest that several immunotherapeutic strategies may prove efficacious and applicable to this group of patients. This review describes the immunogenicity of CRC and presents the most interesting strategies investigated so far: cancer vaccination including antigen-defined vaccination and dendritic cell vaccination, chemo-immunotherapy, and adoptive cell transfer. Future treatment options as well as the possibility of combining existing therapies will be discussed along with the challenges presented by tumor escape mechanisms.
    Original languageEnglish
    JournalScandinavian Journal of Gastroenterology
    Volume47
    Issue number3
    Pages (from-to)315-24
    Number of pages10
    ISSN0036-5521
    DOIs
    Publication statusPublished - Mar 2012

    Fingerprint

    Dive into the research topics of 'Immunotherapy for metastatic colorectal cancer: Present status and new options'. Together they form a unique fingerprint.

    Cite this